APOL1 and chronic kidney disease: In the USA, the higher prevalence of chronic kidney disease and progression to end-stage kidney disease in African Americans than in other population groups might partly be attributable to the presence of chronic kidney disease risk variants of apolipoprotein L1 (APOL1).